State-of-the-art enzyme development company, Entropix, secures investment from LYVA Labs

Entropix, a company creating high-performance enzymes for use across a range of sectors, has secured a six-figure investment from LYVA Labs’ Health and Life Sciences Fund. Entropix specialise in creating novel, high-performance enzymes and biocatalysts for use in diagnostics, pharmaceuticals, food and drink, and plastic recycling, using state-of-the-art molecular biology and machine learning computational methods.